Raymond James Trust N.A. Novartis Ag Transaction History

Raymond James Trust N.A.

  • $4.55 Billion
  • Q3 2024

A detailed history of Raymond James Trust N.A. transactions in Novartis Ag stock. As of the latest transaction made, Raymond James Trust N.A. holds 15,384 shares of NVS stock, worth $1.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,384
Previous 14,421 6.68%
Holding current value
$1.6 Million
Previous $1.54 Million 15.24%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $102,203 - $116,417
963 Added 6.68%
15,384 $1.77 Million
Q2 2024

Jul 25, 2024
BUY
$92.57 - $107.37 $60,448 - $70,112
653 Added 4.74%
14,421 $1.54 Million
Q1 2024

Apr 24, 2024
SELL
$95.27 - $108.47 $3,715 - $4,230
-39 Reduced 0.28%
13,768 $1.33 Million
Q4 2023

Jan 10, 2024
SELL
$92.27 - $101.54 $32,202 - $35,437
-349 Reduced 2.47%
13,807 $1.39 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $6,536 - $7,253
-69 Reduced 0.49%
14,156 $1.44 Million
Q2 2023

Aug 15, 2023
SELL
$92.52 - $104.91 $79,659 - $90,327
-861 Reduced 5.71%
14,225 $1.44 Million
Q1 2023

May 03, 2023
SELL
$80.03 - $92.81 $105,479 - $122,323
-1,318 Reduced 8.03%
15,086 $1.39 Million
Q4 2022

Feb 02, 2023
SELL
$75.55 - $92.52 $14,052 - $17,208
-186 Reduced 1.12%
16,404 $1.49 Million
Q3 2022

Oct 31, 2022
SELL
$74.61 - $87.26 $43,796 - $51,221
-587 Reduced 3.42%
16,590 $1.26 Million
Q2 2022

Jul 14, 2022
SELL
$80.52 - $93.75 $235,279 - $273,937
-2,922 Reduced 14.54%
17,177 $1.45 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $72,179 - $81,648
901 Added 4.69%
20,099 $1.76 Million
Q4 2021

Jan 31, 2022
SELL
$79.7 - $88.13 $53,239 - $58,870
-668 Reduced 3.36%
19,198 $1.68 Million
Q3 2021

Oct 18, 2021
SELL
$81.78 - $95.14 $67,713 - $78,775
-828 Reduced 4.0%
19,866 $1.63 Million
Q2 2021

Jul 20, 2021
SELL
$85.24 - $94.15 $790,686 - $873,335
-9,276 Reduced 30.95%
20,694 $1.89 Million
Q1 2021

May 03, 2021
SELL
$83.5 - $98.47 $670,171 - $790,320
-8,026 Reduced 21.12%
29,970 $2.56 Million
Q4 2020

Jan 13, 2021
SELL
$78.07 - $94.43 $10,539 - $12,748
-135 Reduced 0.35%
37,996 $3.59 Million
Q3 2020

Oct 14, 2020
SELL
$82.14 - $91.0 $213,153 - $236,145
-2,595 Reduced 6.37%
38,131 $3.32 Million
Q2 2020

Jul 16, 2020
BUY
$80.93 - $91.1 $356,415 - $401,204
4,404 Added 12.12%
40,726 $3.56 Million
Q1 2020

Apr 17, 2020
SELL
$70.67 - $99.01 $153,848 - $215,544
-2,177 Reduced 5.65%
36,322 $3 Million
Q4 2019

Jan 14, 2020
BUY
$84.35 - $95.37 $10,881 - $12,302
129 Added 0.34%
38,499 $3.65 Million
Q3 2019

Oct 24, 2019
SELL
$85.54 - $94.26 $1.34 Million - $1.48 Million
-15,649 Reduced 28.97%
38,370 $3.34 Million
Q2 2019

Jul 15, 2019
BUY
$75.4 - $92.8 $357,999 - $440,614
4,748 Added 9.64%
54,019 $4.93 Million
Q1 2019

Apr 15, 2019
BUY
$75.32 - $86.15 $134,672 - $154,036
1,788 Added 3.77%
49,271 $4.74 Million
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $15,615 - $17,388
212 Added 0.45%
47,483 $4.08 Million
Q3 2018

Oct 16, 2018
BUY
$66.94 - $77.43 $933,009 - $1.08 Million
13,938 Added 41.81%
47,271 $4.07 Million
Q2 2018

Jul 11, 2018
BUY
$64.91 - $73.36 $181,358 - $204,967
2,794 Added 9.15%
33,333 $2.52 Million
Q1 2018

Apr 05, 2018
SELL
$70.39 - $84.15 $11,192 - $13,379
-159 Reduced 0.52%
30,539 $2.47 Million
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $78,695 - $84,472
-1,088 Reduced 3.42%
30,698 $2.58 Million
Q3 2017

Oct 24, 2017
BUY
$74.14 - $77.27 $7,191 - $7,495
97 Added 0.31%
31,786 $2.73 Million
Q2 2017

Aug 10, 2017
BUY
N/A
31,689
31,689 $2.65 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email